BrainStorm enrolls first patients in advanced ALS stem cell trial – Nasdaq
KL Daily |
BrainStorm enrolls first patients in advanced ALS stem cell trial
Nasdaq TEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in … BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS Brainstorm Cell Therapeutics Inc. (BCLI) Scheduled to Post Quarterly Earnings on Tuesday |
